Literature DB >> 27192177

Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.

Naying He1, Pei Huang2, Huawei Ling1, Jason Langley3, Chunlei Liu4,5, Bei Ding1, Juan Huang1, Hongmin Xu1, Yong Zhang6, Zhongping Zhang6, Xiaoping Hu3, Shengdi Chen2, Fuhua Yan1.   

Abstract

Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder with variable clinicopathologic phenotypes and underlying neuropathologic mechanisms. Each clinical phenotype has a unique set of motor symptoms. Tremor is the most frequent initial motor symptom of PD and is the most difficult symptom to treat. The dentate nucleus (DN) is a deep iron-rich nucleus in the cerebellum and may be involved in PD tremor. In this study, we test the hypothesis that DN iron may be elevated in tremor-dominant PD patients using quantitative susceptibility mapping. Forty-three patients with PD [19 tremor dominant (TD)/24 akinetic rigidity (AR) dominant] and 48 healthy gender- and age-matched controls were recruited. Multi-echo gradient echo data were collected for each subject on a 3.0-T MR system. Inter-group susceptibility differences in the bilateral DN were investigated and correlations of clinical features with susceptibility were also examined. In contrast with the AR-dominant group, the TD group was found to have increased susceptibility in the bilateral DN when compared with healthy controls. In addition, susceptibility was positively correlated with tremor score in drug-naive PD patients. These findings indicate that iron load within the DN may make an important contribution to motor phenotypes in PD. Moreover, our results suggest that TD and AR-dominant phenotypes of PD can be differentiated on the basis of the susceptibility of the DN, at least at the group level.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Parkinson's disease; akinetic rigidity-dominant phenotype; iron deposition; quantitative susceptibility mapping; tremor-dominant phenotype

Mesh:

Substances:

Year:  2016        PMID: 27192177      PMCID: PMC4906439          DOI: 10.1002/nbm.3554

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  63 in total

1.  High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease.

Authors:  Ashley K Lotfipour; Samuel Wharton; Stefan T Schwarz; V Gontu; Andreas Schäfer; Andrew M Peters; Richard W Bowtell; Dorothee P Auer; Penny A Gowland; Nin P S Bajaj
Journal:  J Magn Reson Imaging       Date:  2011-10-10       Impact factor: 4.813

2.  "Sniffin' sticks": screening of olfactory performance.

Authors:  G Kobal; T Hummel; B Sekinger; S Barz; S Roscher; S Wolf
Journal:  Rhinology       Date:  1996-12       Impact factor: 3.681

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.

Authors:  M M Lewis; G Du; S Sen; A Kawaguchi; Y Truong; S Lee; R B Mailman; X Huang
Journal:  Neuroscience       Date:  2011-01-04       Impact factor: 3.590

6.  Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study.

Authors:  Naroa Ibarretxe-Bilbao; Carme Junque; Maria-Jose Marti; Francesc Valldeoriola; Pere Vendrell; Nuria Bargallo; Mojtaba Zarei; Eduardo Tolosa
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

7.  Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease.

Authors:  Pierre Payoux; Philippe Remy; Philipe Damier; Malika Miloudi; Isabelle Loubinoux; Bernard Pidoux; Véronique Gaura; Olivier Rascol; Yves Samson; Yves Agid
Journal:  Arch Neurol       Date:  2004-08

8.  Course in Parkinson disease subtypes: A 39-year clinicopathologic study.

Authors:  A H Rajput; A Voll; M L Rajput; C A Robinson; A Rajput
Journal:  Neurology       Date:  2009-07-21       Impact factor: 9.910

9.  Improved subthalamic nucleus depiction with quantitative susceptibility mapping.

Authors:  Tian Liu; Sarah Eskreis-Winkler; Andrew D Schweitzer; Weiwei Chen; Michael G Kaplitt; A John Tsiouris; Yi Wang
Journal:  Radiology       Date:  2013-05-14       Impact factor: 11.105

10.  White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study.

Authors:  G Gattellaro; L Minati; M Grisoli; C Mariani; F Carella; M Osio; E Ciceri; A Albanese; M G Bruzzone
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-02       Impact factor: 3.825

View more
  11 in total

1.  Improved Neuroimaging Atlas of the Dentate Nucleus.

Authors:  Naying He; Jason Langley; Daniel E Huddleston; Huawei Ling; Hongmin Xu; Chunlei Liu; Fuhua Yan; Xiaoping P Hu
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  Different iron deposition patterns in Parkinson's disease subtypes: a quantitative susceptibility mapping study.

Authors:  Junling Chen; Tongtong Cai; Yan Li; Jieshan Chi; Siming Rong; Chentao He; Xiaohong Li; Piao Zhang; Lijuan Wang; Yuhu Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-11

Review 3.  A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease.

Authors:  Yuke Zhong; Hang Liu; Guohui Liu; Lili Zhao; Chengcheng Dai; Yi Liang; Juncong Du; Xuan Zhou; Lijuan Mo; Changhong Tan; Xinjie Tan; Fen Deng; Xi Liu; Lifen Chen
Journal:  NPJ Parkinsons Dis       Date:  2022-06-24

Review 4.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

5.  In vivo magnetic resonance imaging and spectroscopy. Technological advances and opportunities for applications continue to abound.

Authors:  Peter van Zijl; Linda Knutsson
Journal:  J Magn Reson       Date:  2019-07-09       Impact factor: 2.229

Review 6.  Rest tremor revisited: Parkinson's disease and other disorders.

Authors:  Wei Chen; Franziska Hopfner; Jos Steffen Becktepe; Günther Deuschl
Journal:  Transl Neurodegener       Date:  2017-06-16       Impact factor: 8.014

7.  Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.

Authors:  Chaewon Shin; Seon Lee; Jee Young Lee; Jung Hyo Rhim; Sun Won Park
Journal:  J Korean Med Sci       Date:  2018-03-26       Impact factor: 2.153

8.  Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.

Authors:  Naying He; Jason Langley; Daniel E Huddleston; Shengdi Chen; Pei Huang; Huawei Ling; Fuhua Yan; Xiaoping Hu
Journal:  Neuroimage Clin       Date:  2020-08-20       Impact factor: 4.881

Review 9.  Neuroimaging Detectable Differences between Parkinson's Disease Motor Subtypes: A Systematic Review.

Authors:  Jackson Tyler Boonstra; Stijn Michielse; Yasin Temel; Govert Hoogland; Ali Jahanshahi
Journal:  Mov Disord Clin Pract       Date:  2020-11-06

10.  Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.

Authors:  Piao Zhang; Junling Chen; Tongtong Cai; Chentao He; Yan Li; Xiaohong Li; Zhenzhen Chen; Lijuan Wang; Yuhu Zhang
Journal:  Front Aging Neurosci       Date:  2022-08-05       Impact factor: 5.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.